USPTO serial 79373372
DINAQUBE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- BONEN-CLARK, HOPE MICHELLE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DINAQUBE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander P. Montgomery
Alexander P. Montgomery Hinckley, Allen & Snyder, LLP28 State Street, 30th FloorBoston, MA 02109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of medicines for heart disease | ACTIVE | — |
| 005 | pharmaceutical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; Medicinal and biomedical preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals in the nature of viral vectors; biological solid organ tissue intended for subsequent implantation; surgical implants made of living tissue; biochemical preparations for the treatment of genetic diseases and cancers; stem cells for medical use; pharmaceutical, medical, biomedical and veterinary preparations, in particular for the treatment of heart diseases | ACTIVE | — |
| 009 | recorded and downloadable computer software and computer software platforms for the development of gene therapies; recorded and downloadable computer software and computer software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, measuring, signaling, detection, testing, inspection, and teaching apparatus and instruments in the nature of high speed cameras, electric sensors and electric actuators, optical 2D scanners, optical filters, and photomultiplier tubes for use in medical, biomedical, veterinary and pharmaceutical research and development; weighing apparatus and instruments for use in medical, biomedical, veterinary and pharmaceutical research and development; data processing and computer equipment in the nature of video-optical recording devices for use in medical, biomedical, veterinary and pharmaceutical research and development | ACTIVE | — |
| 010 | surgical implants comprising artificial material, namely, artificial heart tissue | ACTIVE | — |
| 042 | development and programming of software and computer platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for use in medical, biomedical, veterinary and pharmaceutical research and development; stem cell research services; consulting services relating to medical, biomedical, veterinary and pharmaceutical research and development; research relating to medical, biomedical, veterinary and pharmaceutical research and development; obtaining and providing information and data relating to medical, biomedical, veterinary and pharmaceutical research and development; Biological research and analysis, namely, analysis of human tissue for medical, biomedical, veterinary and pharmaceutical research purposes; design and development of medical diagnostic apparatus; scientific research and development with respect to the isolation and cultivation of human cells and tissues; Programming of computer software for others, namely, programming of software for information platforms on the Internet for use in medical, biomedical, veterinary and pharmaceutical research and development; Rental of laboratory apparatus and instruments for scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detection, testing, inspection and teaching purposes for use in medical, biomedical, veterinary and pharmaceutical research and development; rental and provision for other purposes of computer hardware and data processing equipment for use in medical, biomedical, veterinary and pharmaceutical research and development | ACTIVE | — |
| 044 | providing medical information in the field of medical care as it relates to the preparation and dispensing of medications, in particular for cardiomyopathies and heart failure; Providing medical information and consulting services in the field of medical care as it relates to medical, biomedical, veterinary and pharmaceutical products; genetic screening for medical, biomedical, veterinary and pharmaceutical purposes; human heart tissue bank services; medical services relating to the removal, treatment and processing of stem cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DiNAQOR AG
- Other trademarks owned by DiNAQOR AG
- Other trademarks owned by DiNAQOR AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DINAQUBE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 29, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 9, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 20, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 12, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 12, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 12, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 21, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 29, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |